Health Care & Life Sciences » Biotechnology | Mateon Therapeutics Inc.

Mateon Therapeutics Inc. | Ownership

Companies that own Mateon Therapeutics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Perinvest (UK) Ltd.
210,213
0.51%
-1,000
0.25%
06/30/2017
Invesco Capital Management LLC
10,860
0.03%
0
0%
09/05/2018

About Mateon Therapeutics

View Profile
Address
701 Gateway Boulevard
South San Francisco California 94080
United States
Employees -
Website http://www.mateon.com
Updated 07/08/2019
Mateon Therapeutics, Inc. operates as a clinical stage biopharmaceutical company which develops small molecule injectable drugs for the treatment of cancer. The firm develops OXi4503 for the treatment of acute myeloid leukemia. The OXi4503 has dual mechanism of action which causes the release of leukemic stem cells from the bone marrow and enables their destruction.